Literature DB >> 21601496

Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study.

Konrad Bork1, Jochen Hardt, Petra Staubach-Renz, Guenther Witzke.   

Abstract

OBJECTIVE: Tooth extractions may trigger clinical symptoms of hereditary angioedema due to C1 inhibitor deficiency (HAE-C1-INH). The aim of this study was to determine how many tooth extractions were followed by symptoms of HAE-C1-INH in patients with and without preoperative short-term prophylaxis with C1 inhibitor concentrate. STUDY
DESIGN: Tooth extractions and clinical symptoms of HAE-C1-INH were determined from clinical record files of 171 patients with HAE-C1-INH.
RESULTS: Facial swelling or potentially life-threatening laryngeal edema, or both, occurred in 124/577 tooth extractions (21.5%) without prophylaxis. Similar symptoms occurred in a fewer proportion of patients undergoing extractions (16/128; 12.5%) after short-term prophylaxis with C1 inhibitor concentrate. The graded dose-response relationship was significant at P < .05.
CONCLUSIONS: Short-term prophylaxis with C1 inhibitor concentrate significantly reduces the risk of HAE-C1-INH symptoms after tooth extraction. In some patients, however, facial swellings and laryngeal edema symptoms may occur despite prophylaxis.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601496     DOI: 10.1016/j.tripleo.2011.02.034

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  25 in total

1.  Experimental protocol of dental procedures In patients with hereditary angioedema: the role of anxiety and the use of nitrogen oxide.

Authors:  A Rosa; M Miranda; R Franco; M G Guarino; A Barlattani; P Bollero
Journal:  Oral Implantol (Rome)       Date:  2016-11-13

2.  Anesthetic Management of a Patient With Hereditary Angioedema for Oral Surgery.

Authors:  Rumiko Hosokawa; Masanori Tsukamoto; Saki Nagano; Takeshi Yokoyama
Journal:  Anesth Prog       Date:  2019

3.  Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.

Authors:  Emel Aygören-Pürsün; Daniel Soteres; Dumitru Moldovan; Jim Christensen; Arthur Van Leerberghe; James Hao; Jennifer Schranz; Kraig W Jacobson; Inmaculada Martinez-Saguer
Journal:  Int Arch Allergy Immunol       Date:  2017-06-30       Impact factor: 2.749

4.  A cross-sectional questionnaire assessing patient and physician use of short-term prophylaxis for hereditary angioedema.

Authors:  Maya K Nanda; Umesh Singh; Joyce Wilmot; Jonathan A Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2014-06-11       Impact factor: 6.347

Review 5.  [Angioedema prophylaxis].

Authors:  V Zampeli; M Magerl
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

6.  [Bradykinin-induced angioedema: Definition, pathogenesis, clinical presentation, diagnosis and therapy].

Authors:  J Hahn; M Bas; T K Hoffmann; J Greve
Journal:  HNO       Date:  2015-12       Impact factor: 1.284

7.  Anaesthesia Management of a Patient with Hereditary Angioedema with Prophylactic Administration of C1 Esterase Inhibitor: Case report and literature review.

Authors:  Aravind Narayanan; Rohit R Date; Sanathkumar Birur; Pradipta Bhakta; Sinnakirouchenane Srinivasan
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

8.  An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Authors:  Bernard Floccard; Etienne Hautin; Laurence Bouillet; Brigitte Coppere; Bernard Allaouchiche
Journal:  Core Evid       Date:  2012-09-27

Review 9.  Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema.

Authors:  Ankur Kumar Jindal; Avner Reshef; Hilary Longhurst
Journal:  Clin Rev Allergy Immunol       Date:  2021-05-18       Impact factor: 8.667

Review 10.  Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2.

Authors:  Lauré M Fijen; Konrad Bork; Danny M Cohn
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-09       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.